WATCH - Joe Rogan Joins Trump As He & RFK Jr. Launch $50M Psychedelic Research That Could Treat Mental Health Disorders

In a historic moment that many are calling the official end of the Nixon-era War on Drugs, President Donald Trump signed an executive order in the Oval Office on Saturday, April 18, 2026, aimed at accelerating the research and approval of psychedelic medicines like Ibogaine. The event featured an unlikely alliance between the President, HHS Secretary RFK Jr., and world-renowned podcaster Joe Rogan. Rogan, who has been a vocal critic of the administration's recent military actions in Iran, stood alongside Trump to detail how a private text message exchange led to a total federal policy reversal. The footage is now at the center of a widening controversy because it bypasses decades of standard FDA protocols. Brian Hubbard, an ibogaine advocate who appeared on The Joe Rogan Experience alongside Rick Perry, revealed that the President’s decision came after seeing data on ibogaine’s staggering 80% success rate in treating opioid addiction. According to Rogan, Trump’s response to the proposal was immediate: "Sounds great. Do you want FDA approval? Let’s do it." This "instant green light" has shocked the medical establishment and sparked a massive debate over "Right to Try" laws and the speed of drug approval. What makes this case especially explosive is the administration's direct attack on the 1970 Controlled Substances Act. Hubbard argued in the Oval Office that psychedelics were originally banned not for health reasons, but as a political tool to suppress the anti-war and civil rights movements of the 1970s. By signing this order, Trump is effectively dismantling a cornerstone of Nixon’s legacy. The order allocates $50 million for ibogaine research and directs the FDA to issue "National Priority Vouchers" to fast-track clinical trials into a matter of weeks rather than years. The detail that has triggered growing criticism from some health experts is the known cardiovascular risk associated with ibogaine. While the administration, led by RFK Jr.’s "Make America Healthy Again" (MAHA) mission, views this as a life-saving breakthrough for the 5 million Americans addicted to opiates, critics warn that "speeding up" research on hallucinogens could lead to unforeseen medical consequences. However, Trump remained undeterred, joking during the signing, "I'll take whatever it takes. I don't have time to be depressed." As the "Psychedelic Renaissance" enters the mainstream of U.S. policy, this case is quickly becoming a flashpoint in the larger debate over medical freedom, the legacy of the Drug War, and the legal standards for FDA interference. In this video, we cover: The Ibogaine Breakthrough: Why advocates say this "medicine" can end the opioid crisis. Dismantling Nixon’s Legacy: The political history of the 1970 Controlled Substances Act. RFK Jr. & MAHA: How the Health Secretary is pushing psychedelics into the mainstream.$50 Million for Research: Where the new federal funding for psychedelics is going. Stay updated on Joe Rogan, Trump’s executive orders, ibogaine research, RFK Jr., and the latest breaking health and political developments. #JoeRogan #Trump2026 #Psychedelics #Ibogaine #RFKJr #MAHA #BreakingNews #DrugPolicy #MentalHealth #FDA #OpioidCrisis #Veterans